These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 30137027)

  • 1. The innate immune receptor TREM-1 promotes liver injury and fibrosis.
    Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Arbab AS; Dzutsev A; Sadek R; Trinchieri G; Horuzsko A
    J Clin Invest; 2018 Nov; 128(11):4870-4883. PubMed ID: 30137027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells.
    Hyun J; McMahon RS; Lang AL; Edwards JS; Badilla AD; Greene ME; Stone GW; Pallikkuth S; Stevenson M; Dykxhoorn DM; Kottilil S; Pahwa S; Thomas E
    PLoS Pathog; 2019 Jul; 15(7):e1007883. PubMed ID: 31260499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis.
    Zysset D; Weber B; Rihs S; Brasseit J; Freigang S; Riether C; Banz Y; Cerwenka A; Simillion C; Marques-Vidal P; Ochsenbein AF; Saurer L; Mueller C
    Nat Commun; 2016 Oct; 7():13151. PubMed ID: 27762264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Liver Inflammation and Fibrosis by Interleukin-37.
    Mountford S; Effenberger M; Noll-Puchta H; Griessmair L; Ringleb A; Haas S; Denk G; Reiter FP; Mayr D; Dinarello CA; Tilg H; Bufler P
    Front Immunol; 2021; 12():603649. PubMed ID: 33746950
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage.
    Perugorria MJ; Esparza-Baquer A; Oakley F; Labiano I; Korosec A; Jais A; Mann J; Tiniakos D; Santos-Laso A; Arbelaiz A; Gawish R; Sampedro A; Fontanellas A; Hijona E; Jimenez-Agüero R; Esterbauer H; Stoiber D; Bujanda L; Banales JM; Knapp S; Sharif O; Mann DA
    Gut; 2019 Mar; 68(3):533-546. PubMed ID: 29374630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of TREM1 and TREM2 in Liver-Related Diseases.
    Sun H; Feng J; Tang L
    Cells; 2020 Dec; 9(12):. PubMed ID: 33297569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
    Miura K; Yang L; van Rooijen N; Ohnishi H; Seki E
    Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1310-21. PubMed ID: 22442158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM-1 orchestrates angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm.
    Vandestienne M; Zhang Y; Santos-Zas I; Al-Rifai R; Joffre J; Giraud A; Laurans L; Esposito B; Pinet F; Bruneval P; Raffort J; Lareyre F; Vilar J; Boufenzer A; Guyonnet L; Guerin C; Clauser E; Silvestre JS; Lang S; Soulat-Dufour L; Tedgui A; Mallat Z; Taleb S; Boissonnas A; Derive M; Chinetti G; Ait-Oufella H
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33258804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
    Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
    Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage heterogeneity in liver injury and fibrosis.
    Tacke F; Zimmermann HW
    J Hepatol; 2014 May; 60(5):1090-6. PubMed ID: 24412603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver inflammation and fibrosis.
    Koyama Y; Brenner DA
    J Clin Invest; 2017 Jan; 127(1):55-64. PubMed ID: 28045404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
    Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
    J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM-1 promotes intestinal tumorigenesis.
    Saurer L; Zysset D; Rihs S; Mager L; Gusberti M; Simillion C; Lugli A; Zlobec I; Krebs P; Mueller C
    Sci Rep; 2017 Nov; 7(1):14870. PubMed ID: 29093489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting hepatic macrophages to treat liver diseases.
    Tacke F
    J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner.
    Mai P; Yang L; Tian L; Wang L; Jia S; Zhang Y; Liu X; Yang L; Li L
    J Immunol; 2015 Oct; 195(7):3390-401. PubMed ID: 26320250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
    Karlmark KR; Weiskirchen R; Zimmermann HW; Gassler N; Ginhoux F; Weber C; Merad M; Luedde T; Trautwein C; Tacke F
    Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis.
    Quenum AJI; Shukla A; Rexhepi F; Cloutier M; Ghosh A; Kufer TA; Ramanathan S; Ilangumaran S
    Front Immunol; 2021; 12():749646. PubMed ID: 34712238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV upregulated triggering receptor expressed on myeloid cells-1 (TREM-1) expression on monocytes participated in disease progression through NF-Kb pathway.
    Wu X; Cai B; Lu W; Fu Y; Wei B; Niu Q; Su Z; Li Y; Wang L
    Clin Immunol; 2021 Feb; 223():108650. PubMed ID: 33316373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation.
    López-Navarrete G; Ramos-Martínez E; Suárez-Álvarez K; Aguirre-García J; Ledezma-Soto Y; León-Cabrera S; Gudiño-Zayas M; Guzmán C; Gutiérrez-Reyes G; Hernández-Ruíz J; Camacho-Arroyo I; Robles-Díaz G; Kershenobich D; Terrazas LI; Escobedo G
    Int J Biol Sci; 2011; 7(9):1273-86. PubMed ID: 22110380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytes and macrophages as cellular targets in liver fibrosis.
    Heymann F; Trautwein C; Tacke F
    Inflamm Allergy Drug Targets; 2009 Sep; 8(4):307-18. PubMed ID: 19534673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.